- $2.23bn
- $2.46bn
- $959.40m
- 77
- 59
- 70
- 78
Annual income statement for Synaptics, fiscal year end - June 29th, USD millions except per share, conversion factor applied.
2020 June 27th | 2021 June 30th | 2022 June 25th | 2023 June 24th | 2024 June 29th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 52 W | 52 W | 53 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,334 | 1,340 | 1,740 | 1,355 | 959 |
Cost of Revenue | |||||
Gross Profit | 544 | 611 | 943 | 716 | 440 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,265 | 1,193 | 1,397 | 1,201 | 1,061 |
Operating Profit | 68.9 | 147 | 342 | 154 | -102 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 159 | 120 | 321 | 126 | -125 |
Provision for Income Taxes | |||||
Net Income After Taxes | 121 | 88.7 | 256 | 73.6 | 126 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 119 | 79.6 | 258 | 73.6 | 126 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 119 | 79.6 | 258 | 73.6 | 126 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.15 | 1.57 | 6.74 | 1.83 | 3.6 |